Acute kidney injury in children with moderate-severe COVID-19 and multisystem inflammatory syndrome in children: a referral center experience.
Acute kidney injury
COVID-19
Children
Kidney
Multisystem inflammatory syndrome in children
Journal
Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728
Informations de publication
Date de publication:
07 Sep 2023
07 Sep 2023
Historique:
received:
24
03
2023
accepted:
02
08
2023
revised:
31
07
2023
medline:
7
9
2023
pubmed:
7
9
2023
entrez:
7
9
2023
Statut:
aheadofprint
Résumé
Data on the characteristics of acute kidney injury (AKI) in pediatric COVID-19 and MIS-C are limited. We aimed to define the frequency, associated factors and early outcome of AKI in moderate, severe or critical COVID-19 and MIS-C; and to present a tertiary referral center experience from Türkiye. Hospitalized patients ≤ 18 years of age with confirmed COVID-19 or MIS-C at İhsan Doğramacı Children's Hospital, Hacettepe University, between March 2020-December 2021 were enrolled. The characteristics of AKI in the COVID-19 group were investigated in moderate, severe and critically ill patients; patients with mild COVID-19 were excluded. The median (Q1-Q3) age in the COVID-19 (n = 66) and MIS-C (n = 111) groups was 10.7 years (3.9-15.2) and 8.7 years (4.5-12.7), respectively. The frequency of AKI was 22.7% (15/66) in COVID-19 and 15.3% (17/111) in MIS-C; all MIS-C patients with AKI and 73.3% (11/15) of COVID-19 patients with AKI had AKI at the time of admission. Multivariate analyses revealed need for vasoactive/inotropic agents [Odds ratio (OR) 19.233, p = 0.002] and presence of vomiting and/or diarrhea (OR 4.465, p = 0.036) as independent risk factors of AKI in COVID-19 patients; and need for vasoactive/inotropic agents (OR 22.542, p = 0.020), procalcitonin and ferritin levels as independent risk factors of AKI in the MIS-C group. Age was correlated with lymphocyte count (r = -0.513, p < 0.001) and troponin level (r = 0.518, p < 0.001) in MIS-C patients. Length of hospital stay was significantly longer in both groups with AKI, compared to those without AKI. Mortality was 9.1% in the COVID-19 group; and was associated with AKI (p = 0.021). There was no mortality in MIS-C patients. AKI recovery at discharge was 63.6% in COVID-19 survivors and 100% in MIS-C patients. Independent risk factors for AKI were need for vasoactive/inotropic agents and vomiting/diarrhea in moderate, severe or critical COVID-19 patients; and need for vasoactive/inotropic agents and severe inflammation in MIS-C patients. Our findings suggest that inflammation and cardiac dysfunction are associated with AKI in MIS-C patients; and the association with age in this group merits further studies in larger groups. Early outcome is favorable; long-term follow-up for kidney functions is needed. A higher resolution version of the Graphical abstract is available as Supplementary information.
Sections du résumé
BACKGROUND
BACKGROUND
Data on the characteristics of acute kidney injury (AKI) in pediatric COVID-19 and MIS-C are limited. We aimed to define the frequency, associated factors and early outcome of AKI in moderate, severe or critical COVID-19 and MIS-C; and to present a tertiary referral center experience from Türkiye.
METHODS
METHODS
Hospitalized patients ≤ 18 years of age with confirmed COVID-19 or MIS-C at İhsan Doğramacı Children's Hospital, Hacettepe University, between March 2020-December 2021 were enrolled. The characteristics of AKI in the COVID-19 group were investigated in moderate, severe and critically ill patients; patients with mild COVID-19 were excluded.
RESULTS
RESULTS
The median (Q1-Q3) age in the COVID-19 (n = 66) and MIS-C (n = 111) groups was 10.7 years (3.9-15.2) and 8.7 years (4.5-12.7), respectively. The frequency of AKI was 22.7% (15/66) in COVID-19 and 15.3% (17/111) in MIS-C; all MIS-C patients with AKI and 73.3% (11/15) of COVID-19 patients with AKI had AKI at the time of admission. Multivariate analyses revealed need for vasoactive/inotropic agents [Odds ratio (OR) 19.233, p = 0.002] and presence of vomiting and/or diarrhea (OR 4.465, p = 0.036) as independent risk factors of AKI in COVID-19 patients; and need for vasoactive/inotropic agents (OR 22.542, p = 0.020), procalcitonin and ferritin levels as independent risk factors of AKI in the MIS-C group. Age was correlated with lymphocyte count (r = -0.513, p < 0.001) and troponin level (r = 0.518, p < 0.001) in MIS-C patients. Length of hospital stay was significantly longer in both groups with AKI, compared to those without AKI. Mortality was 9.1% in the COVID-19 group; and was associated with AKI (p = 0.021). There was no mortality in MIS-C patients. AKI recovery at discharge was 63.6% in COVID-19 survivors and 100% in MIS-C patients.
CONCLUSIONS
CONCLUSIONS
Independent risk factors for AKI were need for vasoactive/inotropic agents and vomiting/diarrhea in moderate, severe or critical COVID-19 patients; and need for vasoactive/inotropic agents and severe inflammation in MIS-C patients. Our findings suggest that inflammation and cardiac dysfunction are associated with AKI in MIS-C patients; and the association with age in this group merits further studies in larger groups. Early outcome is favorable; long-term follow-up for kidney functions is needed. A higher resolution version of the Graphical abstract is available as Supplementary information.
Identifiants
pubmed: 37676500
doi: 10.1007/s00467-023-06125-3
pii: 10.1007/s00467-023-06125-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
Références
Lin L, Wang X, Ren J, Sun Y, Yu R, Li K, Zheng L, Yang J (2020) Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open 10:e042573. https://doi.org/10.1136/bmjopen-2020-042573
doi: 10.1136/bmjopen-2020-042573
pubmed: 33172950
Wang X, Chen X, Tang F, Luo W, Fang J, Qi C, Sun H, Xiao H, Peng X, Shao J (2021) Be aware of acute kidney injury in critically ill children with COVID-19. Pediatr Nephrol 36:163–169. https://doi.org/10.1007/s00467-020-04715-z
doi: 10.1007/s00467-020-04715-z
pubmed: 32844290
Stewart DJ, Hartley JC, Johnson M, Marks SD, du Pré P, Stojanovic J (2020) Renal dysfunction in hospitalised children with COVID-19. Lancet Child Adolesc Health 4:e28–e29. https://doi.org/10.1016/S2352-4642(20)30178-4
doi: 10.1016/S2352-4642(20)30178-4
pubmed: 32553126
pmcid: 7295466
Bjornstad EC, Krallman KA, Askenazi D, Zappitelli M, Goldstein SL, Basu RK; Investigators SPARC (2021) Preliminary assessment of acute kidney injury in critically Ill children associated with SARS-CoV-2 infection: a multicenter cross-sectional analysis. Clin J Am Soc Nephrol 16:446–448. https://doi.org/10.2215/CJN.11470720
doi: 10.2215/CJN.11470720
pubmed: 33144276
Deep A, Bansal M, Ricci Z (2021) Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care. Blood Purif 50:150–160. https://doi.org/10.1159/000509677
doi: 10.1159/000509677
pubmed: 32663827
Ng JH, Bijol V, Sparks MA, Sise ME, Izzedine H, Jhaveri KD (2020) Pathophysiology and pathology of acute kidney injury in patients with COVID-19. Adv Chronic Kidney Dis 27:365–376. https://doi.org/10.1053/j.ackd.2020.09.003
doi: 10.1053/j.ackd.2020.09.003
pubmed: 33308501
pmcid: 7574722
Chopra S, Saha A, Kumar V, Thakur A, Pemde H, Kapoor D, Ray S, Das A, Pandit K, Gulati A, Sharma AG, Singh P, Sodani R (2021) Acute Kidney Injury in Hospitalized Children with COVID19. J Trop Pediatr 67:fmab037. https://doi.org/10.1093/tropej/fmab037
doi: 10.1093/tropej/fmab037
pubmed: 34080011
Raina R, Mawby I, Chakraborty R, Sethi SK, Mathur K, Mahesh S, Forbes M (2022) Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data. PLoS One 17:e0266737. https://doi.org/10.1371/journal.pone.0266737
doi: 10.1371/journal.pone.0266737
pubmed: 35472149
pmcid: 9041802
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P (2020) Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395:1607–1608. https://doi.org/10.1016/S0140-6736(20)31094-1
doi: 10.1016/S0140-6736(20)31094-1
pubmed: 32386565
pmcid: 7204765
Toraih EA, Hussein MH, Elshazli RM, Kline A, Munshi R, Sultana N, Taghavi S, Killackey M, Duchesne J, Fawzy MS, Kandil E (2021) Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis. World J Pediatr 17:141–151. https://doi.org/10.1007/s12519-021-00419-y
doi: 10.1007/s12519-021-00419-y
pubmed: 33608839
pmcid: 7895741
Tripathi AK, Pilania RK, Bhatt GC, Atlani M, Kumar A, Malik S (2023) Acute kidney injury following multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: a systematic review and meta-analysis. Pediatr Nephrol 38:357–370. https://doi.org/10.1007/s00467-022-05701-3
doi: 10.1007/s00467-022-05701-3
pubmed: 35943577
Centers for Disease Control and Prevention (2023) Multisystem Inflammatory Syndrome (MISC). https://www.cdc.gov/mis-c/cases/index.html . Accessed 14 Mar 2023
COVID-19 Treatment Guidelines Panel. National Institutes of Health (2023) Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/ . Accessed 20 Mar 2023
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138
Zappitelli M, Parikh CR, Akcan-Arikan A, Washburn KK, Moffett BS, Goldstein SL (2008) Ascertainment and epidemiology of acute kidney injury varies with definition interpretation. Clin J Am Soc Nephrol 3:948–954. https://doi.org/10.2215/CJN.05431207
doi: 10.2215/CJN.05431207
pubmed: 18417742
pmcid: 2440279
Grewal MK, Gregory MJ, Jain A, Mohammad D, Cashen K, Ang JY, Thomas RL, Valentini RP (2021) Acute Kidney Injury in Pediatric Acute SARS-CoV-2 Infection and Multisystem Inflammatory Syndrome in Children (MIS-C): Is There a Difference? Front Pediatr 9:692256. https://doi.org/10.3389/fped.2021.692256
doi: 10.3389/fped.2021.692256
pubmed: 34434905
pmcid: 8380850
Lurbe E, Agabiti-Rosei E, Cruickshank JK et al (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34:1887–1920. https://doi.org/10.1097/HJH.0000000000001039
doi: 10.1097/HJH.0000000000001039
pubmed: 27467768
Margossian R, Schwartz ML, Prakash A et al (2009) Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study). Am J Cardiol 104:419–428. https://doi.org/10.1016/j.amjcard.2009.03.058
doi: 10.1016/j.amjcard.2009.03.058
pubmed: 19616678
pmcid: 2741330
Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, Yanovski JA (2017) Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 102:709–757. https://doi.org/10.1210/jc.2016-2573
doi: 10.1210/jc.2016-2573
pubmed: 28359099
pmcid: 6283429
Basalely A, Gurusinghe S, Schneider J, Shah SS, Siegel LB, Pollack G, Singer P, Castellanos-Reyes LJ, Fishbane S, Jhaveri KD, Mitchell E, Merchant K, Capone C, Gefen AM, Steinberg J, Sethna CB (2021) Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19. Kidney Int 100:138–145. https://doi.org/10.1016/j.kint.2021.02.026
doi: 10.1016/j.kint.2021.02.026
pubmed: 33675848
pmcid: 7927648
Deep A, Upadhyay G, du Pré P et al (2020) Acute Kidney Injury in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic: Experience From PICUs Across United Kingdom. Crit Care Med 48:1809–1818. https://doi.org/10.1097/CCM.0000000000004662
doi: 10.1097/CCM.0000000000004662
pubmed: 33044282
Stewart DJ, Mudalige NL, Johnson M, Shroff R, du Pré P, Stojanovic J (2022) Acute kidney injury in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) is not associated with progression to chronic kidney disease. Arch Dis Child 107:e21. https://doi.org/10.1136/archdischild-2021-322866
doi: 10.1136/archdischild-2021-322866
pubmed: 34862182
Lara D, Young T, Del Toro K, Chan V, Ianiro C, Hunt K, Kleinmahon J (2020) Acute Fulminant Myocarditis in a Pediatric Patient With COVID-19 Infection. Pediatrics 146:e20201509. https://doi.org/10.1542/peds.2020-1509
doi: 10.1542/peds.2020-1509
pubmed: 32747591
Sanna G, Serrau G, Bassareo PP, Neroni P, Fanos V, Marcialis MA (2020) Children’s heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur J Pediatr 179:1079–1087. https://doi.org/10.1007/s00431-020-03699-0
doi: 10.1007/s00431-020-03699-0
pubmed: 32474800
pmcid: 7261213
Kesici S, Aykan HH, Orhan D, Bayrakci B (2020) Fulminant COVID-19-related myocarditis in an infant. Eur Heart J 41:3021. https://doi.org/10.1093/eurheartj/ehaa515
doi: 10.1093/eurheartj/ehaa515
pubmed: 32531024
Morello W, Vianello FA, Proverbio E, Peruzzi L, Pasini A, Montini G (2022) COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area. Pediatr Nephrol 37:757–764. https://doi.org/10.1007/s00467-021-05330-2
doi: 10.1007/s00467-021-05330-2
pubmed: 34687377
Canpolat N, Yıldırım ZY, Yıldız N et al (2022) COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation. Eur J Pediatr 181:117–123. https://doi.org/10.1007/s00431-021-04191-z
doi: 10.1007/s00431-021-04191-z
pubmed: 34218318
Sethi SK, Rana A, Adnani H, McCulloch M, Alhasan K, Sultana A, Safadi R, Agrawal N, Raina R (2021) Kidney involvement in multisystem inflammatory syndrome in children: a pediatric nephrologist’s perspective. Clin Kidney J 14:2000–2011. https://doi.org/10.1093/ckj/sfab073
doi: 10.1093/ckj/sfab073
pubmed: 34471522
pmcid: 8083308
Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP, Leung JW, Tsang CA, Pierce TJ, Kennedy JL, Hammett TA, Belay ED (2021) Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health 5:323–331. https://doi.org/10.1016/S2352-4642(21)00050-X
doi: 10.1016/S2352-4642(21)00050-X
pubmed: 33711293
pmcid: 7943393
Stasiak A, Perdas E, Smolewska E (2022) Risk factors of a severe course of pediatric multi-system inflammatory syndrome temporally associated with COVID-19. Eur J Pediatr 181:3733–3738. https://doi.org/10.1007/s00431-022-04584-8
doi: 10.1007/s00431-022-04584-8
pubmed: 35948653
pmcid: 9364844
Dain AS, Raffini L, Whitworth H (2022) Thrombotic events in critically ill children with coronavirus disease 2019 or multisystem inflammatory syndrome in children. Curr Opin Pediatr 34:261–267. https://doi.org/10.1097/MOP.0000000000001130
doi: 10.1097/MOP.0000000000001130
pubmed: 35634699
pmcid: 9197313
Shi Q, Wang Z, Liu J, Wang X, Zhou Q, Li Q, Yu Y, Luo Z, Liu E, Chen Y; COVID-19 evidence and recommendations working group (2021) Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis. EClinicalMedicine 41:101155. https://doi.org/10.1016/j.eclinm.2021.101155
Sık G, Inamlık A, Akçay N et al (2023) Mortality risk factors among critically ill children with MIS-C in PICUs: a multicenter study. Pediatr Res 22:1–8. https://doi.org/10.1038/s41390-023-02518-0
doi: 10.1038/s41390-023-02518-0